Autoimmunity and hepatitis a vaccine in children

Journal of Investigational Allergology and Clinical Immunology

Volumn 21, Issue 5, 2011, Pages 389-393

  Karali, Z ^a   Tanir Basaranoglu, S ^a   Karali, Y ^a   Oral, B ^a   Kilic, S S ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

ANA; Anti cardiolipin antibody; Autoimmunity; Hepatitis a vaccine

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MICROSOME ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID; SMOOTH MUSCLE ANTIBODY; THYROID ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; MALE; PRESCHOOL CHILD; SEROLOGY; SIDE EFFECT; VACCINATION;

ADOLESCENT; ANTIBODY FORMATION; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS A VACCINES; HUMANS; MALE; TURKEY; VACCINATION;

EID: 80051775112     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol. 2009;5:648-652
2. Rose NR. Immunologic hazards associated with vaccination of humans. J Autoimmun. 2000;14:11-13
3. Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity--friends or foes? Trends Immunol. 2009;30:409-414
4. Gruenewald R, Ropper AH, Lior H, Chan J, Lee R, Molinaro VS. Serologic evidence of Campylobacter jejuni/coli enteritis in children with Guillain-Barré syndrome. Arch Neurol. 1991; 48:1080-1082
5. Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, Clark S, Haber P, Stolley PD, Schonberger LB, Chen RT. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 infl uenza vaccines. N Engl J Med. 1998;339:1797-1802
6. Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Adjuvants and autoimmunity. Lupus. 2009;18:1217-1225
7. Gherardi RK, Authier FJ. Aluminum inclusion macrophagic myofasciitis: a recently identified condition. Immunol Allergy Clin North Am. 2003;23:699-712
8. Petrik MS, Wong MC, Tabata RC, Garry RF, Shaw CA. Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice. Neuromolecular Med. 2007;9:83-100
9. Asa PB, Wilson RB, Garry RF. Antibodies to squalene in recipients of anthrax vaccine. Exp Mol Pathol. 2002;73:19-27
10. Bell BP, Feinstone SM, Hepatitis A. vaccine.In: Plotkin SA, Orenstein WA eds.Vaccines, By. 4th ed.Elsevier Inc 2004: 269-297
11. Berry PA, Smith-Laing G. Hepatitis A vaccine associated with autoimmune hepatitis. World J Gastroenterol. 2007;13:2238-2239
12. Perumalswami P, Peng L, Odin JA. Vaccination as a triggering event for autoimmune hepatitis. Semin Liver Dis. 2009;29:331-334
13. Stangos A, Zaninetti M, Petropoulos I, Baglivo E, Pournaras C. Multiple evanescent white dot syndrome following simultaneous hepatitis-A and yellow fever vaccination. Ocul Immunol Infl amm. 2006;14:301-304
14. Del Giudice G, Podda A, Rappuoli R. What are the limits of adjuvanticity? Vaccine. 2001;20:38-41
15. Harel M, Aron-Maor A, Sherer Y, Blank M, Shoenfeld Y. The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity. Immunobiology 2005;210:743-747
16. Yu O, Bohlke K, Hanson CA, Delaney K, Rees TG, Zavitkovsky A, Ray P, Mullooly J, Black SB, Benson P, Thompson WW, Davis RL, Jackson LA. Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study. Pharmacoepidemiol Drug Saf. 2007;16: 736-745
17. Classen JB, Classen DC. Clustering of cases of insulin dependent diabetes (IDDM) occurring three years after hemophilusinfl uenza B (HiB) immunization support causal relationship between immunization and IDDM. Autoimmunity. 2002; 35:247-253
18. Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, Chen RT. Guillain-Barré syndrome following infl uenza vaccination. JAMA. 2004;292:2478-2481
19. Mikaeloff Y, Caridade G, Suissa S, Tardieu M. Hepatitis B vaccine and the risk of CNS infl ammatory demyelination in childhood. Neurology. 2009;72:873-880
20. Kelly H. Evidence for a causal association between oral polio vaccine and transverse myelitis: A case history and review of the Literature. J Paediatr Child Health. 2006;42:155-159
21. Geier DA, Geier MR. A one year followup of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database. Clin Exp Rheumatol. 2002;20:767-771
22. Maillefert JF, Tonolli-Serabian I, Cherasse A, Demoux AL, Tavernier C, Piroth L. Arthritis following combined vaccine against diphtheria, polyomyelitis, and tetanus toxoid. Clin Exp Rheumatol. 2000;18:255-256
23. Toplak N, Kveder T, Trampus-Bakija A, Subelj V, Cucnik S, Avcin T. Autoimmune response following annual infl uenza vaccination in 92 apparently healthy adults. Autoimmun Rev. 2008;8:134-138
24. Toplak N, Avcin T. Vaccination of healthy subjects and autoantibodies: from mice through dogs to humans. Lupus. 2009;18:1186-1191
25. Martinuc P.J, Avcin T, Bozic B, Kuhar M, Cucnik S, Zupancic M, Prosenc K, Kveder T, Rozman B. Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine.Clin Exp Immunol. 2005;142:377-380
26. Pool V, Chen R, Rhodes P. Indications for measles-mumpsrubella vaccination in a child with prior thrombocytopenia purpura. Pediatr Infect Dis J. 1997;16:423-424
27. Knip M, Korhonen S, Kulmala P, Veijola R, Reunanen A, Raitakari OT, Viikari J, Akerblom HK. Prediction of type 1 diabetes in the general population. Diabetes Care. 2010 Jun;33(6):1206-1212.